FDA Inspection 1202586 — Maxwell B. Sauder, M.D.
The FDA completed an inspection of Maxwell B. Sauder, M.D. on April 6, 2023 in North York. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 6, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North York (Canada)
Additional Details
Clinical Investigator (CI)